Click to open contact form.
Your Global Partners in the Business of Innovation

Michael A. Yamin, Ph.D.

  • Scientific Advisor
  • New York
Michael helps companies and clients establish, manage and expand their worldwide intellectual property portfolios in alignment with company goals and to keep ahead of industry trajectories. He uses his experience in patent prosecution, drug discovery, clinical operations, CMC and business development to establish IP of quality and value.

BIOGRAPHY

Dr. Michael Yamin is a Scientific Advisor in the Life Sciences Group in Pearl Cohen’s New York office. Michael works primarily in patent drafting, worldwide patent prosecution, patent strategy planning, and portfolio management in the life sciences and biotechnology areas. His technical experience includes pharmaceuticals, formulations, small molecules, molecular biology, immunology, biochemistry, pharmacology, and cellular and developmental biology.

Prior to joining Pearl Cohen, Michael worked at various companies in the New York City area, including Angion Biomedica Corp., Warren Pharmaceuticals, Inc., Mojave Therapeutics, Inc., The Picower Institute for Medical Research, Innapharma, Inc., and Alteon Inc. He was also a research associate at The Rockefeller University. Michael is also a member of the board of directors of Angion Biomedica Corp.

Publications:

  • Dana D, Gadhiya SV, St Surin LG, Li D, Naaz F, Ali Q, Paka L, Yamin MA, Narayan M, Goldberg ID, Narayan P. Deep Learning in Drug Discovery and Medicine; Scratching the Surface. Molecules. 2018 Sep 18;23(9). pii: E2384. doi: 10.3390/molecules23092384. Review.
  • Paka P, Huang B, Duan B, Li JS, Zhou P, Paka L, Yamin MA, Friedman SL, Goldberg ID, Narayan P. A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease. World J Nephrol. 2018 Sep 7;7(5):96-107. doi: 10.5527/wjn.v7.i5.96.
  • Hwang A, Shi C, Zhu E, Naaz F, Zhou P, Rasheed Z, Liu M, Jung LS, Duan B, Li J, Jiang K, Paka L, Gadhiya SV, Dana D, Ali Q, Yamin MA, Goldberg ID, Narayan P. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH. PLoS One. 2018 Jun 26;13(6):e0198937. doi: 10.1371/journal.pone.0198937. eCollection 2018.
  • Nieto JA, Zhu J, Duan B, Li J, Zhou P, Paka L, Yamin MA, Goldberg ID, Narayan P. A modified elliptical formula to estimate kidney collagen content in a model of chronic kidney disease. PLoS One. 2018 Jan 19;13(1):e0190815. doi: 10.1371/journal.pone.0190815. eCollection 2018.
  • Nieto JA, Yamin MA, Goldberg ID, Narayan P. An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal Recessive Polycystic Kidney Disease-The Nieto-Narayan Formula. PLoS One. 2016 Oct 3;11(10):e0163063. doi: 10.1371/journal.pone.0163063. eCollection 2016. Erratum in: PLoS One. 2016 Dec 9;11(12 ):e0168319.
  • Narayan P, Duan B, Jiang K, Li J, Paka L, Yamin MA, Friedman SL, Weir MR, Goldberg ID. Late intervention with the small molecule BB3 mitigates postischemic kidney injury. Am J Physiol Renal Physiol. 2016 Aug 1;311(2):F352-61. doi: 10.1152/ajprenal.00455.2015. Epub 2016 Jun 1.